Renew Biotechnologies CEO Chad Pollard
Theinnovationpioneerstartupentrepreneurinnovationpioneerstartupentrepreneurcapital of the world.
Utah's Startup & Tech Community
Renew Biotechnologies CEO & Co-Founder Chad Pollard
Chad Pollard is the CEO and Co-Founder of Renew Biotechnologies, a leader in nanopore-based next-generation sequencing (NGS) diagnostics. He attended Brigham Young University where he graduated in Genetics, Genomics, and Biotechnology and continued his education into a P.h.D in Cell Biology and Physiology. During his P.h.D. he specialized in Neurodegenerative Diseases and developed a novel blood test to detect Alzheimer's, ALS, and Parkinson's before symptoms appear. That test became one of Renew's Flagship assays. More importantly he has an incredible wife Sarah and they have two kids Jayden and Hailey.
Renew Biotechnologies
Renew Biotechnologies is a biotech company that focuses on molecular diagnostics, specializing in the development and commercialization of cutting-edge technologies derived from Oxford Nanopore Technologies (ONT). The company operates under a unique business model, managing a portfolio of brands that hold or actively develop molecular diagnostic technologies. Each brand is structured to function independently, allowing for tailored commercialization strategies and focused growth without impacting the overall asset management of the parent company. Renew’s core mission is to enhance precision diagnostics and personalized care through innovative technology solutions, fundamentally transforming patient outcomes in various medical fields.
Weekly Newsletter
Utah Tech & Business
Subscribe to stay up-to-date on everything happening inside Silicon Slopes.